Homeβ€ΊSearchβ€ΊNature Biotechnology

Nature Biotechnology

Nature Research Β· United Kingdom Β· Est. 1941

ISSN1546-1696
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJR
96
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (3 more)+18
Total96
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
248
days submission β†’ published
measured Β· last 5 articles Β· accept 220d
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
23.109
H-Indexi
629
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
6.431
Total Worksi
19,346
Total Citationsi
1,847,606
2yr Mean Citednessi
11.22
Open Impact Factor alternative
Retractions
6
Source: Retraction Watch

Aims & Scope

Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences as well as covers the commercial, political, ethical, legal, and societal aspects of this research. The first function is fulfilled by the peer-reviewed research section, the second by the expository efforts in the front of the journal. We provide researchers with news about business; we provide the business community with news about research developments. The core areas in which we are actively seeking research papers include: molecular engineering of nucleic acids and proteins; molecular therapy (therapeutics genes, antisense, siRNAs, aptamers, DNAzymes, ribozymes, peptides, proteins); large-scale biology (genomics, functional genomics, proteomics, structural genomics, metabolomics, etc.); computational biology (algorithms and modeling), regenerative medicine (stem cells, tissue engineering, biomaterials); imaging technology; analytical biotechnology (sensors/detectors for analytes/macromolecules), applied immunology (antibody engineering, xenotransplantation, T-cell therapies); food and agricultural biotechnology; and environmental biotechnology. A comprehensive list of areas of interest is shown below. Genetic engineering Strategies for controlling gene expression Strategies for manipulating gene structure Strategies for gene containment Large-scale approaches Technologies for analyzing gene function (e.g., arrays, SAGE) Technologies for analyzing gene structure/organization (e.g., molecular beacons) Chemogenomics or chemical genetics Pharmacogenomics/SNPs Computational analysis Proteomics Technologies for analyzing/identifying protein structure/function (e.g., 2-D gels, mass spectrometry, yeast two-hybrid, SPR, NMR, arrays and chips) Structural genomics Computational analysis Metabolomics Technologies for analyzing/profiling metabolites (chromatography, mass spectrometry) Computational analysis Computational biology Bioinformatics; algorithms; data deconvolution Modeling and systems biology: kinetics-based models and constraints-based models Molecular engineering Rational approaches for proteins/antibodies/enzymes/drugs Molecular evolution Molecular breeding approaches Metabolic engineering Genetic manipulation of species of interest to modify or allow the production of a commercially or therapeutically relevant compound Computational analysis Novel expression systems Mammalian cells Insect cells Bacteria Fungi Plant cells Delivery of genes, drugs, or cells Targeting strategies Viral and nonviral vector strategies Imaging Reporter molecules Imaging approaches/technologies for visualizing whole animals, cells, or single molecules Computational analysis Nucleic acid therapeutics Gene therapy (targeting, expression, integration, immunogenicity) Antisense RNAi DNAzymes and ribozymes Other (e.g., chimeric oligonucleotides/triple helix) Nanobiotechnology Nanomaterials for use in drug delivery or as therapeutics Nanomaterials for use in industrial biotechnology Nanosensors Nanosystems for imaging molecules and cells Vaccines and applied immunology Antibody engineering T-cell therapies Therapies exploiting innate immunity (e.g. complement) Antigen delivery vectors and approaches Nucleic acid vaccines Computational analysis Regenerative medicine Stem cells Tissue engineering Therapeutic cloning (somatic cell nuclear transfer) Xenotransplantation Biomaterials Biosensors Approaches for detecting biological molecules Use of biological systems in detecting analytes Assay systems Approaches for multiplexing and increasing throughput Selection/screening strategies for gene/proteins/drugs Microfluidics Biomaterials Engineering materials for biological application Molecular imprinting Biomimetics Nanotechnology Agbiotech and transgenic plants Crop improvement (resis

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published1941
FrequencyThirteen No. A Year
StatusActive (last: 2026)
Total Publications19,346
Publisher OrgNature Portfolio
Visit Journal Website

Submission Info

Peer Reviewpeer-reviewed
Review Timeβ€”
Acceptance Rateβ€”
OA Licenseβ€”
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes

Think.Check.Submit Compliance

8/12 Β· 67%
βœ…
Do you know the journal / publisher?
Nature Research
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
1546-1696
βœ…
Indexed in a trusted database?
WoS, Scopus
βœ…
Peer review process documented?
peer-reviewed
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
βœ…
Plagiarism detection in place?
Yes
❌
Listed in DOAJ (verified OA)?
N/A
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
418
113k
2019
426
77k
2020
395
34k
2021
429
33k
2022
466
32k
2023
468
11k
2024
438
2.6k
2025
244
204
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Applied Microbiology and BiotechnologyQ1
BioengineeringQ1
Biomedical EngineeringQ1
BiotechnologyQ1
Molecular MedicineQ1

Subject Classification

Web of Science Categories

Biotechnology & Applied Microbiology

Scopus Categories

BiotechnologyBioengineeringBiomedical EngineeringApplied Microbiology and BiotechnologyMolecular Medicine

Research Topics (OpenAlex)

Biotechnology and Related FieldsScience, Research, and MedicineCRISPR and Genetic EngineeringBiomedical Ethics and RegulationRNA and protein synthesis mechanismsMonoclonal and Polyclonal Antibodies ResearchGenetically Modified Organisms ResearchRNA Interference and Gene DeliveryAdvanced biosensing and bioanalysis techniquesBiomedical and Engineering Education

Frequently asked questions about Nature Biotechnology

Is Nature Biotechnology a predatory journal?

PubScope has no integrity flags on record for Nature Biotechnology: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Nature Biotechnology?

Nature Biotechnology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 11.22.

Is Nature Biotechnology indexed in Scopus and Web of Science?

Nature Biotechnology is indexed in Web of Science, Scopus.

What is the aims and scope of Nature Biotechnology?

Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences as well as covers the commercial, political, ethical, legal, and societal aspects of this research. The first function is fulfilled by the peer-reviewed research section, the second by the expository efforts in the front of the journal. We provide researchers with news about business; we provide the business community with news about research developments. The core ar

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref